Edition:
United States

HPGC Renmintongtai Pharmaceutical Corp (600829.SS)

600829.SS on Shanghai Stock Exchange

12.24CNY
--
Change (% chg)

-- (--)
Prev Close
¥12.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,721,286
52-wk High
¥16.06
52-wk Low
¥11.60

Summary

Name Age Since Current Position

Zhenping Zhang

56 2017 Chairman of the Board

Weidong Zhu

47 2016 General Manager, Director

Hui Li

39 2013 Director

Xiaodong Meng

42 Director

Dong Wang

39 2010 Independent Director

Yuanqing Wang

50 2010 Independent Director

Biographies

Name Description

Zhenping Zhang

Weidong Zhu

Hui Li

Mr. Li Hui has been serving as Director in Harbin PharmGroup Sanjing Pharmaceutical Co., Ltd. since April 9, 2013. He was Assistant General Manager in the Company. He is also Executive Deputy General Manager in another company which he served as Deputy General Manager. He holds a Master's degree.

Xiaodong Meng

Mr. Meng Xiaodong is Director of Harbin Pharm Group Sanjing Pharm Co Ltd. He also serves as Secretary of the Board and Deputy General Manager in Harbin Pharmaceutical Group Co., Ltd.

Dong Wang

Mr. Wang Dong has been Independent Director in Harbin Pharm Group Sanjing Pharm Co Ltd since March 15, 2010. He is also Director and Deputy General Manager in an accounting firm, as well as Independent Director in two other companies. He holds a Master of Business Administration (MBA). He was Chief Financial Officer in a Harbin-based investment company.

Yuanqing Wang

Basic Compensation

Name Fiscal Year Total

Zhenping Zhang

--

Weidong Zhu

--

Hui Li

324,500

Xiaodong Meng

--

Dong Wang

50,000

Yuanqing Wang

50,000
As Of  30 Dec 2012

Options Compensation